Skip to main content
Equibles

Invesco Ltd.

Position in RDY — Dr Reddys Laboratories Ltd

CIK 914208 Atlanta, GA
Back to RDY Full portfolio

Position in RDY

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$7,390,943
+$1,411,567 QoQ
Shares Held
510,072
+18.1% QoQ
Ownership
0.061%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#29
of 238 holders
Holding Since
Sep 2020
23 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in RDY Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

Invesco Ltd. holds $1,945,758,306 across 45 Drug Manufacturers - Specialty & Generic names. RDY ranks #21 (0.4% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ZTS
Zoetis Inc.
 5,523,018 $396,884,069
2 VTRS
Viatris Inc
 20,771,275 $329,847,840
3 UTHR
UNITED THERAPEUTICS Corp
 473,109 $256,344,645
4 NBIX
Neurocrine Biosciences Inc
 1,077,317 $181,571,000
5 ELAN
Elanco Animal Health Inc
 5,306,326 $130,588,679
6 TEVA
Teva Pharmaceutical Industries Ltd
 3,430,011 $116,208,767
7 INDV
Indivior Pharmaceuticals, Inc.
 1,842,983 $75,617,590
8 COLL
Collegium Pharmaceutical, Inc
 1,882,499 $68,146,461

All Filings in RDY

Export CSV
23 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $7,390,943 510,072
2026-03-31 $5,979,376 431,724
2025-12-31 $5,224,157 372,091
2025-09-30 $4,386,168 313,746
2025-06-30 $3,807,730 253,342
2025-03-31 $3,105,386 235,435
2024-12-31 $3,211,748 203,404
2024-09-30 $2,929,956 36,878
2024-06-30 $2,666,345 34,996
2024-03-31 $2,313,164 31,536
2023-12-31 $3,839,145 55,176
2023-09-30 $3,713,959 55,540
2023-06-30 $4,219,092 66,853
2023-03-31 $3,841,123 67,471
2022-12-31 $4,459,090 86,166
2022-09-30 $3,799,517 72,593
2022-06-30 $203,003 3,665
2022-03-31 $4,499,305 80,734
2021-12-31 $877,278 13,412
2021-09-30 $798,094 12,252
2021-06-30 $1,519,966 20,677
2020-12-31 $1,279,868 17,953
2020-09-30 $1,378,122 19,812